Skip to main content
. 2016 Dec 12;32(2):221–230. doi: 10.3346/jkms.2017.32.2.221

Table 1. Sequence and schedule of KNOW-CKD Study clinic visits and procedures.

Parameters Screen Baseline 6 mon 1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr 9 yr 10 yr
Informed consent
Demographic information
Medical history
Eligibility confirmation
Recent events
Medications
Health related questionnaire
HRQOL questionnaire
BP
Anthropometric measures
CBC, chemistry
IDMS-traceable Cr, eGFR
Cystatin C
HbA1c (diabetic subjects)
Lipid panel, CRP, iron panel
Intact PTH, 25(OH)D, 1,25(OH)D, troponin T
UA with microscopy
24HU – Ca/P/Cr/Urea/Uric acid/protein
ECG, chest X-ray
Spot urine e', albumin, protein, osmolality, Cr
EchoCG, PWV, ABI, Coronary CT, LS spine lateral X-ray, DEXA BMD
Biosamples for DNA
Plasma/urine biosample
Fundus exam (DNsubgroup)
Abdomen CT (PKD subgroup)
Family screen (PKD subgroup)

KNOW-CKD = KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease, HRQOL = health-related quality of life, BP = blood pressure, CBC = complete blood count, Cr = creatinine, eGFR = estimated glomerular filtration rate, HbA1c = hemoglobin A1c, CRP = C-reactive protein, UA = urinalysis, 24HU = 24-hour urine, ECG = electrocardiogram, PTH = parathyroid hormone, 25(OH)D = 25-hydroxyvitamin D, 1,25(OH)D = 1,25-dihydroxyvitamin D, EchoCG = echocardiography, PWV = pulse wave velocity, ABI = ankle-brachial index, CT = computerized tomography, LS = lumbosacral spine, DEXA BMD = dual energy x-ray absorptiometry bone mineral density, DN = diabetic nephropathy, PKD = polycystic kidney disease.